ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,430.40
      0.14%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      84.575
      -0.25%
      Bitcoin
      65,218.17
      0.12%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Deciphera Pharmaceuticals Inc (DCPH)

      7. Deciphera Pharmaceuticals Inc (DCPH) News

      DCPH

      Deciphera Pharmaceuticals (DCPH)

      Deciphera Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:DCPH
      DateTimeSourceHeadlineSymbolCompany
      01/11/202212:53PMTipRanksDeciphera Pharmaceuticals: Restructuring Plan Was Necessary for SurvivalNASDAQ:DCPHDeciphera Pharmaceuticals Inc
      01/10/20226:05PMTipRanksDeciphera Pharmaceuticals (DCPH) Gets a Hold Rating from JMP SecuritiesNASDAQ:DCPHDeciphera Pharmaceuticals Inc
      01/10/202210:29AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:DCPHDeciphera Pharmaceuticals Inc
      01/10/20227:14AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DCPHDeciphera Pharmaceuticals Inc
      01/10/20227:00AMBusiness WireDeciphera Pharmaceuticals Provides Corporate Update and Highlights Key 2022 Corporate MilestonesNASDAQ:DCPHDeciphera Pharmaceuticals Inc
      01/03/20227:00AMBusiness WireDeciphera Pharmaceuticals, Inc. to Present at the 40th Annual J.P. Morgan Healthcare ConferenceNASDAQ:DCPHDeciphera Pharmaceuticals Inc
      12/22/20217:00AMTipRanksMHRA Authorizes Deciphera’s QINLOCK in the U.K.NASDAQ:DCPHDeciphera Pharmaceuticals Inc
      12/21/20218:44AMBusiness WireDeciphera Announces Approval of QINLOCK® in the United Kingdom for the Treatment of Fourth-Line Gastrointestinal Stromal TumorNASDAQ:DCPHDeciphera Pharmaceuticals Inc
      12/17/20214:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DCPHDeciphera Pharmaceuticals Inc
      12/17/20214:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DCPHDeciphera Pharmaceuticals Inc
      12/17/20214:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DCPHDeciphera Pharmaceuticals Inc
      12/02/20217:47AMTipRanksLeerink Partners Thinks Deciphera Pharmaceuticals’ Stock is Going to RecoverNASDAQ:DCPHDeciphera Pharmaceuticals Inc
      12/02/202112:45AMTipRanksDeciphera Pharmaceuticals (DCPH) Receives a Hold from JMP SecuritiesNASDAQ:DCPHDeciphera Pharmaceuticals Inc
      12/01/20217:39AMTipRanksJonesTrading Keeps Their Sell Rating on Deciphera Pharmaceuticals (DCPH)NASDAQ:DCPHDeciphera Pharmaceuticals Inc
      11/30/20218:42AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DCPHDeciphera Pharmaceuticals Inc
      11/30/20218:30AMBusiness WireDeciphera Pharmaceuticals Announces Restructuring to Prioritize Clinical Development Programs and Streamline Commercial OperationsNASDAQ:DCPHDeciphera Pharmaceuticals Inc
      11/22/20217:25AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DCPHDeciphera Pharmaceuticals Inc
      11/22/20217:00AMBusiness WireDeciphera Receives European Commission Approval of QINLOCK® for the Treatment of Fourth-Line Gastrointestinal Stromal TumorNASDAQ:DCPHDeciphera Pharmaceuticals Inc
      11/10/20214:35PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DCPHDeciphera Pharmaceuticals Inc
      11/08/20216:16AMTipRanksDeciphera Reveals Topline Results of INTRIGUE Phase 3 Clinical Study; Shares CrashNASDAQ:DCPHDeciphera Pharmaceuticals Inc
      11/05/20217:00AMBusiness WireDeciphera Pharmaceuticals Announces Top-Line Results from the INTRIGUE Phase 3 Clinical StudyNASDAQ:DCPHDeciphera Pharmaceuticals Inc
      11/02/20214:12PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:DCPHDeciphera Pharmaceuticals Inc
      11/02/20214:09PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DCPHDeciphera Pharmaceuticals Inc
      11/02/20214:01PMBusiness WireDeciphera Pharmaceuticals, Inc. Announces Third Quarter 2021 Financial ResultsNASDAQ:DCPHDeciphera Pharmaceuticals Inc
      10/26/20217:00AMBusiness WireDeciphera Pharmaceuticals to Announce Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 2, 2021NASDAQ:DCPHDeciphera Pharmaceuticals Inc
      10/12/20217:00AMBusiness WireDeciphera Announces Approval of QINLOCK® in Switzerland for the Treatment of Fourth-Line Gastrointestinal Stromal TumorNASDAQ:DCPHDeciphera Pharmaceuticals Inc
      10/07/20219:00AMBusiness WireDeciphera Presents Preclinical Data from DCC-3116 Program at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer TherapeuticsNASDAQ:DCPHDeciphera Pharmaceuticals Inc
      10/06/20214:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DCPHDeciphera Pharmaceuticals Inc
      09/29/20214:02PMEdgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:DCPHDeciphera Pharmaceuticals Inc
      09/17/20214:02PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DCPHDeciphera Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:DCPH